Arcellx (ACLX) Total Current Liabilities (2021 - 2025)

Arcellx's quarterly Total Current Liabilities came in at $104.2 million in Q4 2025, down 16.91% year-on-year from $125.4 million in Q4 2024, and down 11.99% quarter-over-quarter from $118.4 million in Q3 2025.

Arcellx has reported Total Current Liabilities for 5 years, with the latest figure at $104.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 16.91% year-over-year to $104.2 million; the trailing twelve-month figure through Dec 2025 stood at $104.2 million (down 16.91% YoY), and the FY2025 full-year result was $104.2 million, down 16.91% from the prior year.
  • Total Current Liabilities for Q4 2025 stood at $104.2 million, down from $118.4 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $173.1 million in Q3 2023, with the low at $14.4 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $99.0 million, with a median of $112.5 million recorded in 2025.
  • Year-over-year, Total Current Liabilities jumped 1051.18% in 2023 and plunged 43.45% in 2024.
  • Tracing ACLX's Total Current Liabilities over 5 years: stood at $14.8 million in 2021, then soared by 281.9% to $56.7 million in 2022, then jumped by 108.56% to $118.2 million in 2023, then grew by 6.06% to $125.4 million in 2024, then slipped by 16.91% to $104.2 million in 2025.
  • The last three Total Current Liabilities figures came in at $104.2 million (Q4 2025), $118.4 million (Q3 2025), and $121.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 Arcellx 6.48 Bn 6.48 Bn - 104.20 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 104.20 Mn
Sep 30, 2025 118.39 Mn
Jun 30, 2025 121.85 Mn
Mar 31, 2025 112.46 Mn
Dec 31, 2024 125.41 Mn
Sep 30, 2024 137.02 Mn
Jun 30, 2024 88.29 Mn
Mar 31, 2024 107.90 Mn
Dec 31, 2023 118.24 Mn
Sep 30, 2023 173.15 Mn
Jun 30, 2023 156.11 Mn
Mar 31, 2023 166.06 Mn
Dec 31, 2022 56.69 Mn
Sep 30, 2022 44.78 Mn
Jun 30, 2022 23.73 Mn
Mar 31, 2022 14.43 Mn
Dec 31, 2021 14.85 Mn